Xiaorong Lin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Radiation Induced

Papillary Thyroid

Cancer Stem Cells

Top Venues

Cancer management and research

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Lisha Wu, Hongyan Huang, Yimin Zhang, Wei Zhuang, Xiaorong Lin
Post-marketing safety concern of PI3K inhibitors in the cancer therapies: an 8-year disproportionality analysis from the FDA adverse event reporting system. Expert opinion on drug safety (2024)
Shouying Li, Jiaxin Feng, Haiyan Weng, Feng Zhao, Guohui Cui, Wenkui Fu, Xiaorong Lin, Hai Hu
Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer. Cancer management and research 14 (2022)